Entry |
|
Name |
Antithrombosis agents |
Class |
|
Pathway map |
|
Compound |
D00106 | Epoprostenol (USAN/INN) |
D00769 | Clopidogrel bisulfate (USP) |
D01028 | Ticlopidine hydrochloride (JP18/USP) |
D01029 | Tirofiban hydrochloride (USAN) |
D01280 | Warfarin potassium (JP18) |
D01337 | Epoprostenol sodium (JAN/USAN) |
D01551 | Beraprost sodium (JP18/USAN) |
D01624 | Sarpogrelate hydrochloride (JP18) |
D01670 | Nafamostat mesylate (USAN) |
D01672 | Gabexate mesilate (JP18) |
D01844 | Fondaparinux sodium (JAN/USP/INN) |
D01896 | Cilostazol (JP18/USP/INN) |
D01981 | Ximelagatran (JAN/USAN/INN) |
D02112 | Heparin sodium (JP18/USP/INN) |
D02956 | Anticoagulant heparin (USP) |
D02980 | Adomiparin sodium (USAN) |
D03213 | Apixaban (JAN/USAN/INN) |
D03324 | Nasaruplase (cell culture) (JAN) |
D03341 | Urokinase (JP18/USAN/INN) |
D03353 | Dalteparin sodium (JAN/USP/INN) |
D03960 | Aspirin and dialuminate |
D05123 | Nasaruplase beta (USAN/INN) |
D06270 | Urokinase alfa (USAN/INN) |
D06571 | Antithrombin III human (USP) |
D07082 | Dabigatran etexilate mesylate (USAN) |
D07086 | Rivaroxaban (JAN/USAN/INN) |
D07144 | Dabigatran etexilate (USAN/INN) |
D08795 | Human antithrombin III, freeze-dried concentrated |
D09546 | Edoxaban tosilate hydrate (JAN) |
D09817 | Darexaban maleate (JAN) |
|
Reference |
|
Authors |
Morishima Y, Shibano T |
Title |
[Research and development strategy of antithrombotic agents: pharmacology of the oral factor Xa-inhibitor edoxaban]. |
Journal |
|
Reference |
|
Authors |
Ohmura T, Takahashi I, Ikegami K, Encinas J |
Title |
[Pharmacological and clinical profiles of the direct thrombin inhibitor dabigatran etexilate methane sulfate (Prazaxa((R))) ]. |
Journal |
|
Reference |
|
Authors |
Tomiyama Y. |
Title |
[Types and their mechanism of action of antiplatelet drugs] (In Japanese) |
Journal |
CLINICIAN |
LinkDB |
|